SomnoMed breaks sales records
SomnoMed announced today that in Q4 of FY15 it had broken sales records in all three geographic regions – North America, Europe and APAC/Japan, recording a year on year growth for the quarter of 21.2%. During the three months period sales reached 14,517 units, the highest quarterly unit sales in the history of SomnoMed. Quarterly sales in North America exceeded of 8,000 units; Europe sold over 5,000 units and the combined APAC/Japan region sold over 1,400 units. Revenue is expected to be A$32.5m on unit sales of 51,355 (in line with our forecast). The market will like this update. (SOM, Add, Price Target A$3.23). Here is the link to the blog site: (VIEW LINK)
1 stock mentioned
Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
No areas of expertise